Zevra Therapeutics company info

What does Zevra Therapeutics do?
Zevra Therapeutics (NASDAQ:ZVRA) focuses on developing and commercializing a diverse portfolio targeting pain management and related conditions. Engaged in innovation-driven projects, Zevra aims to provide advanced therapeutic solutions to improve the quality of life for patients suffering from chronic and acute conditions. The company's objectives include progressing its pipeline through clinical trials, obtaining regulatory approvals for its candidates, and establishing strategic partnerships to maximize its market presence and impact. With a patient-centric approach, Zevra Therapeutics strives to address unmet medical needs by utilizing cutting-edge research and development to bring novel treatments to market.
Zevra Therapeutics company media
Company Snapshot

Is Zevra Therapeutics a public or private company?

key
Ownership
Public

How many people does Zevra Therapeutics employ?

people
Employees
77

What sector is Zevra Therapeutics in?

pie chart
Sector
Health Care

Where is the head office for Zevra Therapeutics?

location pin
Head Office
Florida, United States

What year was Zevra Therapeutics founded?

founded flag
Year Founded
2006
What does Zevra Therapeutics specialise in?
/Pharmaceutical Development /Oncology Therapies /Immuno-Oncology /Drug Discovery /Preclinical Research /Patent Portfolio

What are the products and/or services of Zevra Therapeutics?

Overview of Zevra Therapeutics offerings
Research & Development: Zevra conducts research to identify and develop potential therapies for rare diseases.
Preclinical Development: Zevra perform laboratory and animal studies to evaluate the safety and efficacy of their drug candidates.
Clinical Trial Development: Zevra designs and conducts clinical trials to assess the safety and effectiveness of their drug candidates in humans.
Regulatory Affairs: They manage the regulatory approval process with agencies like the FDA to get their drugs approved for market.
Manufacturing Partnerships: Zevra might partner with other companies for large-scale manufacturing of their drugs once approved.
Commercialization Planning: In the future, they might plan for commercialization activities such as marketing and sales of their approved drugs (although they currently don't have any).

Who is in the executive team of Zevra Therapeutics?

Zevra Therapeutics leadership team
  • Mr. Neil F. McFarlane
    Mr. Neil F. McFarlane
    President, CEO & Director
  • Ms. Christal M. M. Mickle M.A.
    Ms. Christal M. M. Mickle M.A.
    Co-Founder & Chief Development Officer
  • Mr. R. LaDuane Clifton CPA
    Mr. R. LaDuane Clifton CPA
    CFO, Secretary & Treasurer
  • Mr. Joshua M. Schafer M.B.A.
    Mr. Joshua M. Schafer M.B.A.
    Chief Commercial Officer & Executive VP of Business Development
  • Dr. Sven  Guenther Ph.D.
    Dr. Sven Guenther Ph.D.
    Chief Scientific Officer
  • Ms. Nichol L. Ochsner
    Ms. Nichol L. Ochsner
    Vice President of Investor Relations & Corporate Communications
  • Dr. Christopher M. Lauderback Ph.D.
    Dr. Christopher M. Lauderback Ph.D.
    Senior Vice President of Manufacturing
  • Dr. Rene A. Braeckman Ph.D.
    Dr. Rene A. Braeckman Ph.D.
    Senior Vice President of Clinical Development